The effects of the SGLT2 inhibitors on the Japanese type 2 diabetes patients with chronic kidney disease

被引：0
|
作者：
Kobayashi, K. [1 ]
Sato, K. [1 ]
Hatori, N. [1 ]
Miyakawa, M. [1 ]
Toyoda, M. [2 ]
机构：
[1] Kanagawa Physicians Assoc, Comm Hyperetens & Kidney Dis, Yokohama, Kanagawa, Japan
[2] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa, Japan
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
903
引用
收藏
页码：S418 / S418
页数：1
相关论文
共 50 条
  • [1] The Kidney Effects of the SGLT2 Inhibitors on the Japanese Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease
    Kobayashi, Kazuo
    Toyoda, Masao
    Hatori, Nobuo
    Sakai, Hiroyuki
    Furuki, Takayuki
    Tamura, Kouichi
    Miyakawa, Masaaki
    [J]. DIABETES, 2019, 68
  • [2] Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease
    Scheen, Andre J.
    Delanaye, Pierre
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (01) : 35 - 46
  • [3] SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
    David C. Wheeler
    June James
    Dipesh Patel
    Adie Viljoen
    Amar Ali
    Marc Evans
    Kevin Fernando
    Debbie Hicks
    Nicola Milne
    Philip Newland-Jones
    John Wilding
    [J]. Diabetes Therapy, 2020, 11 : 2757 - 2774
  • [4] SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
    Wheeler, David C.
    James, June
    Patel, Dipesh
    Viljoen, Adie
    Ali, Amar
    Evans, Marc
    Fernando, Kevin
    Hicks, Debbie
    Milne, Nicola
    Newland-Jones, Philip
    Wilding, John
    [J]. DIABETES THERAPY, 2020, 11 (12) : 2757 - 2774
  • [5] Efficacy and safety profile of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
    Scheen, Andre J.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 243 - 256
  • [6] Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
    Kelly, Michael S.
    Lewis, Jelena
    Huntsberry, Ashley M.
    Dea, Lauren
    Portillo, Ivan
    [J]. POSTGRADUATE MEDICINE, 2019, 131 (01) : 31 - 42
  • [7] Effects of SGLT2 Inhibitors on Gut Microbiota in Japanese Patients with Type 2 Diabetes
    Kusunoki, Masataka
    Hisano, Fumiya
    Matsuda, Shin-Ichi
    Miyata, Tetsuro
    [J]. DIABETES, 2023, 72
  • [8] SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
    Kanduri, Swetha R.
    Kovvuru, Karthik
    Hansrivijit, Panupong
    Thongprayoon, Charat
    Vallabhajosyula, Saraschandra
    Pivovarova, Aleksandra I.
    Chewcharat, Api
    Garla, Vishnu
    Medaura, Juan
    Cheungpasitporn, Wisit
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09)
  • [9] SGLT2 Inhibitors for the Prevention of Kidney Failure in Patients with Type 2 Diabetes
    Pavlicek, Vojtech
    [J]. DIABETOLOGE, 2019, 15 (07): : 663 - 664
  • [10] Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
    Scheen, Andre J.
    [J]. CLINICAL PHARMACOKINETICS, 2015, 54 (07) : 691 - 708
12345